100 related articles for article (PubMed ID: 6129649)
1. Bromocriptine in tardive dyskinesia.
Häggström JE; Andersson U; Gunne LM
Pharmacopsychiatria; 1982 Sep; 15(5):161-3. PubMed ID: 6129649
[TBL] [Abstract][Full Text] [Related]
2. [Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)].
Ringwald E
Pharmakopsychiatr Neuropsychopharmakol; 1978 Nov; 11(6):294-8. PubMed ID: 33397
[TBL] [Abstract][Full Text] [Related]
3. The behavioral toxicity of bromocriptine in patients with psychiatric illness.
Perovich RM; Lieberman JA; Fleischhacker WW; Alvir J
J Clin Psychopharmacol; 1989 Dec; 9(6):417-22. PubMed ID: 2574194
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic measures in tardive dyskinesia].
Tegeler J; Wöller W
Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic trial of gamma-vinyl GABA, an inhibitor of GABA transaminase, in tardive dyskinesias induced by neuroleptics].
Lambert PA; Cantiniaux P; Chabannes JP; Tell GP; Schechter PJ; Koch-Weser J
Encephale; 1982; 8(3):371-6. PubMed ID: 6137357
[TBL] [Abstract][Full Text] [Related]
6. [Use and value of the therapeutic neuroleptic-bromocriptine combination in schizophrenia].
Lombertie ER; Durelle G; Fuseau A
Ann Med Psychol (Paris); 1995 Oct; 153(8):531-4. PubMed ID: 8561400
[TBL] [Abstract][Full Text] [Related]
7. [Effect of high single doses of bromocriptine in schizophrenic patients with elevated serum prolactin levels and extrapyramidal side effects associated with neuroleptic treatment (author's transl)].
Ringwald E; Lustig A; Moscovici M; Spiegel R; Vamos E
Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):318-24. PubMed ID: 6111093
[TBL] [Abstract][Full Text] [Related]
8. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
[TBL] [Abstract][Full Text] [Related]
10. [Never treated schizophrenic patients have no abnormal movements such as tardive dyskinesia].
Chorfi M; Moussaoui D
Encephale; 1985; 11(6):263-5. PubMed ID: 2869939
[TBL] [Abstract][Full Text] [Related]
11. [Tardive dyskinesia after low doses of neuroleptics and attempts at treatment].
Marsálek M
Cesk Psychiatr; 1989 Apr; 85(2):100-5. PubMed ID: 2567213
[TBL] [Abstract][Full Text] [Related]
12. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
Lee JG; Shin BS; Lee YC; Park SW; Kim YH
Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
[TBL] [Abstract][Full Text] [Related]
13. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
Ezrin-Waters C; Seeman MV; Seeman P
J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715
[TBL] [Abstract][Full Text] [Related]
14. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?
Levin H; Chengappa KN; Kambhampati RK; Mahdavi N; Ganguli R
J Clin Psychiatry; 1992 Jul; 53(7):248-51. PubMed ID: 1353492
[TBL] [Abstract][Full Text] [Related]
15. [Two cases of tardive Tourette syndrome].
Yamauchi K; Ohmori T
Seishin Shinkeigaku Zasshi; 2006; 108(5):459-65. PubMed ID: 16869393
[TBL] [Abstract][Full Text] [Related]
16. Effect of clozapine in severe tardive dyskinesia: a case report.
Meltzer HY; Luchins DJ
J Clin Psychopharmacol; 1984 Oct; 4(5):286-7. PubMed ID: 6149239
[TBL] [Abstract][Full Text] [Related]
17. Tardive dyskinesia and depressive illness.
Davis KL; Berger PA; Hollister LE
Psychopharmacol Commun; 1976; 2(2):125-30. PubMed ID: 10603
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis.
Wolf ME; DeWolfe AS; Mosnaim AD
Hillside J Clin Psychiatry; 1987; 9(1):3-11. PubMed ID: 2888712
[TBL] [Abstract][Full Text] [Related]
19. Vitamin E in the treatment of tardive dyskinesia.
Akhtar S; Jajor TR; Kumar S
J Postgrad Med; 1993; 39(3):124-6. PubMed ID: 7914238
[TBL] [Abstract][Full Text] [Related]
20. [Utility of quetiapine in tardive dyskinesia].
Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
